Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emory researchers' single-site PMA for LASIK excimer system slated for panel review July 11.

This article was originally published in The Gray Sheet

Executive Summary

EMORY UNIV. PHYSICIANS' SINGLE-SITE LASIK PMA TO GET PANEL REVIEW July 11 by FDA's Ophthalmic Devices Panel at the Gaithersburg Hilton in Maryland. The physician-sponsored premarket approval application covers use of a modified Summit Omnimed excimer laser for treating myopia of -2.0 to -22.0 diopters via the laser in situ keratomileusis procedure. The PMA is being sponsored by Atlanta-based Vision Correction Group, Inc., which is comprised of physicians practicing at the Emory University Vision Correction Center.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008303

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel